SEC Form 4 · accession 0001144204-16-077563
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Garr
Officer — CEO · Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 28, 2016 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 27, 2016 | M | 19,802 | $0.00 | A | 1,456,269 | D | |
| Common StockF1 | Jan 27, 2016 | F | 6,465 | $0.67 | D | 1,449,804 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1 | — | Jan 27, 2016 | M | 19,802 | D | Jan 27, 2016 | — | Common Stock | 19,802 | 0 | D |
Explanation of responses
- F1Represents the conversion of restricted stock units into Common Stock. On January 27, 2016, the reporting person was granted 19,802 shares of Common Stock, of which 6,465 shares were forfeited for tax withholding purposes.
- F2Each restricted stock unit represents a right to receive one share of Neuralstem's common stock.